Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Turrisi

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of the National Cancer Institute|February 1, 1995
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancerW T Sause, C Scott, S Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1993
Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysisM B Hazuka, A T Turrisi, S T Lutz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
Use of Veff and iso-NTCP in the implementation of dose escalation protocolsR K Ten Haken, M K Martel, M L Kessler, et al.
Cancer|November 7, 2000
Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinomaA R Yuen, G Zou, A T Turrisi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Toxicity of WR-2721 administered in single and multiple dosesM M Kligerman, D J Glover, A T Turrisi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1994
Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinusesW H Roa, M B Hazuka, H M Sandler, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 1999
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsM K Martel, R K Ten Haken, M B Hazuka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805K S Albain, V W Rusch, J J Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trialJ A Hayman, M K Martel, R K Ten Haken, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancerC R Thomas, D J Giroux, L M Janaki, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|February 1, 1995
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancerW T Sause, C Scott, S Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1993
Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysisM B Hazuka, A T Turrisi, S T Lutz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
Use of Veff and iso-NTCP in the implementation of dose escalation protocolsR K Ten Haken, M K Martel, M L Kessler, et al.
Cancer|November 7, 2000
Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinomaA R Yuen, G Zou, A T Turrisi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Toxicity of WR-2721 administered in single and multiple dosesM M Kligerman, D J Glover, A T Turrisi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1994
Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinusesW H Roa, M B Hazuka, H M Sandler, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 1999
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsM K Martel, R K Ten Haken, M B Hazuka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805K S Albain, V W Rusch, J J Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trialJ A Hayman, M K Martel, R K Ten Haken, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancerC R Thomas, D J Giroux, L M Janaki, et al.
Pageof 7